CDNA Insider Trading

Insider Ownership Percentage: 4.90%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $3,150,415.19

CareDx Insider Trading History Chart

This chart shows the insider buying and selling history at CareDx by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$2M$0$2MTotal Insider BuyingTotal Insider Selling

CareDx Share Price & Price History

Current Price: $17.96
Price Change: Price Decrease of -0.39 (-2.13%)
As of 03/28/2025 05:00 PM ET

This chart shows the closing price history over time for CDNA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$17.96Closing price on 03/29/25:

SEC Filings (Institutional Ownership Changes) for CareDx (NASDAQ:CDNA)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CDNA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$115Mbought$90MsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$100M-$50M$0$50M$100MTotal InflowsTotal Outflows
CareDx logo
CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.
Read More on CareDx

Today's Range

Now: $17.96
Low: $17.77
High: $18.31

50 Day Range

MA: $21.39
Low: $17.64
High: $24.91

52 Week Range

Now: $17.96
Low: $7.42
High: $34.84

Volume

357,406 shs

Average Volume

846,890 shs

Market Capitalization

$995.45 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.95

Who are the company insiders with the largest holdings of CareDx?

CareDx's top insider investors include:
  1. Reginald Seeto (Insider)
  2. Peter Maag (Director)
  3. Alexander L Johnson (Insider)
Learn More about top insider investors at CareDx.

Who are the major institutional investors of CareDx?

CareDx's top institutional investors include:
  1. Vanguard Group Inc. — 9.06%
  2. ARK Investment Management LLC — 4.49%
  3. Bamco Inc. NY — 4.12%
  4. Fred Alger Management LLC — 3.01%
  5. Invesco Ltd. — 2.82%
  6. Sumitomo Mitsui Trust Group Inc. — 2.79%
Learn More about top institutional investors of CareDx stock.

Which major investors are selling CareDx stock?

Within the previous quarter, CDNA stock was sold by these institutional investors:
  1. Bellevue Group AG
  2. ARK Investment Management LLC
  3. Bank of Montreal Can
  4. Boston Partners
  5. Bank of America Corp DE
  6. Cubist Systematic Strategies LLC
  7. Russell Investments Group Ltd.
  8. Driehaus Capital Management LLC
In the last year, company insiders that have sold CareDx company stock include:
  1. Reginald Seeto (Insider)
  2. Peter Maag (Director)
Learn More investors selling CareDx stock.

Which major investors are buying CareDx stock?

During the last quarter, CDNA stock was purchased by institutional investors including:
  1. Divisadero Street Capital Management LP
  2. Jacobs Levy Equity Management Inc.
  3. Bamco Inc. NY
  4. Vanguard Group Inc.
  5. Intrinsic Edge Capital Management LLC
  6. Next Century Growth Investors LLC
  7. AQR Capital Management LLC
  8. Point72 Asset Management L.P.